We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-15.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.5M
AUM Growth
-$23M
Cap. Flow
-$2.06M
Cap. Flow %
-2.89%
Top 10 Hldgs %
68.62%
Holding
96
New
11
Increased
4
Reduced
26
Closed
18

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.13M
2
CVX icon
Chevron
CVX
+$2.64M
3
DVN icon
Devon Energy
DVN
+$2.48M
4
U icon
Unity
U
+$1.49M
5
ET icon
Energy Transfer Partners
ET
+$1.43M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.23M
2
ARWR icon
Arrowhead Research
ARWR
+$2.48M
3
SSYS icon
Stratasys
SSYS
+$1.74M
4
LNTH icon
Lantheus
LNTH
+$1.71M
5
AIRS icon
AirSculpt Technologies
AIRS
+$942K

Sector Composition

Rank Sector Weight
1 Healthcare 66.98%
2 Energy 21.36%
3 Technology 7.65%
4 Materials 1.27%
5 Communication Services 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTH
76
DELISTED
Genetron Holdings Limited ADS
GTH
$13K 0.02%
2,500
– –
AIRS icon
77
AirSculpt Technologies
AIRS
$349M
$9K 0.01%
1,500
-100,000
-99% -$942K
RNAZ icon
78
TransCode Therapeutics
RNAZ
$4.5M
– –
0
– –
ABNB icon
79
Airbnb
ABNB
$90.5B
– –
-50
Closed -$9K
AFRM icon
80
Affirm
AFRM
$26.3B
– –
-7,000
Closed -$324K
AKRO
81
DELISTED
Akero Therapeutics
AKRO
– –
-10,000
Closed -$142K
APLT
82
DELISTED
Applied Therapeutics
APLT
– –
-20,000
Closed -$42K
ATNM icon
83
Actinium Pharmaceuticals
ATNM
$23.5M
– –
-6,500
Closed -$33K
AVDL
84
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-10,500
Closed -$72K
BTAI icon
85
BioXcel Therapeutics
BTAI
$26M
– –
-1,250
Closed -$418K
COIN icon
86
Coinbase
COIN
$39.5B
– –
-3,000
Closed -$570K
CRIS icon
87
Curis
CRIS
$8.85M
– –
-200
Closed -$190K
GLBE icon
88
Global E Online
GLBE
$6.98B
– –
-12,500
Closed -$422K
NKTR icon
89
Nektar Therapeutics
NKTR
$2.47B
– –
-400
Closed -$32K
NVDA icon
90
NVIDIA
NVDA
$5.31T
– –
-155,000
Closed -$4.23M
RRC icon
91
Range Resources
RRC
$8.91B
– –
-30,000
Closed -$911K
UPST icon
92
Upstart Holdings
UPST
$2.89B
– –
-5,500
Closed -$600K
MTTR
93
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
– –
-40,000
Closed -$325K
AVGR
94
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
-117
Closed -$6K
GNCA
95
DELISTED
Genocea Biosciences, Inc.
GNCA
– –
-5,000
Closed -$6K
BHVN
96
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-2,100
Closed -$249K
1 2 3
4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, ACT Capital Management held 96 positions worth $71.5M, down 24% from $94.5M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ACT Capital Management's Q2 2022 filing shows 11 new, 4 increased, 26 reduced and 18 closed positions. Its largest new stake was ExxonMobil: 56,900 shares worth $4.87M. The largest sale was NVIDIA, an estimated $4.23M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 76% a quarter earlier, followed by Energy and Technology.

  • ACT Capital Management's largest Q2 2022 buy was ExxonMobil: 56,900 shares worth $4.87M.
  • ACT Capital Management added most to Chevron in Q2 2022, an estimated $2.64M increase.
  • ACT Capital Management's biggest Q2 2022 reduction was Arrowhead Research, cutting an estimated $2.48M.
  • ACT Capital Management fully exited NVIDIA in Q2 2022, selling an estimated $4.23M.
  • ACT Capital Management's ten largest holdings make up 69% of its $71.5M portfolio in Q2 2022.
  • ACT Capital Management opened 11 new positions and closed 18 in Q2 2022.
  • ACT Capital Management's portfolio value fell 24% quarter-over-quarter to $71.5M.

Based on ACT Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.